Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950923 · ClinicalTrials.gov registry record · Phase 1
Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01950923 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants.
The verdict
NCT01950923, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies sildenafil citrate before surgery in improving kidney function in patients with kidney cancer. Sildenafil citrate may help protect the kidney from the side effects of surgery and improve kidney function after surgery.
Interventions
- OTHER placebo
- PROCEDURE therapeutic conventional surgery
- DRUG sildenafil citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950923
The ClinicalTrials.gov registry entry for NCT01950923 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01950923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01950923 about?
NCT01950923 is a clinical study titled "Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer". This randomized pilot clinical trial studies sildenafil citrate before surgery in improving kidney function in patients with kidney cancer. Sildenafil citrate may help protect the kidney from the side effects of surgery and improve kidney function after surgery.
What is the current status of trial NCT01950923?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2013-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01950923?
The interventions under investigation include: placebo (OTHER), therapeutic conventional surgery (PROCEDURE), sildenafil citrate (DRUG).
Who is sponsoring clinical trial NCT01950923?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.